EG546901 Inhibitors
Vmn1r34, a vomeronasal type 1 receptor, is a key player in the molecular machinery governing chemosensory responses, particularly in the detection and transduction of pheromonal signals. This G protein-coupled receptor (GPCR) is predominantly expressed in the vomeronasal organ, where it functions as a molecular sensor for chemosensory cues, contributing to social and reproductive behaviors in various species. The activation of Vmn1r34 is intricately linked to specific signaling pathways, and a comprehensive understanding of its inhibition involves the intricate modulation of these pathways. Wortmannin and LY294002, for example, directly inhibit Vmn1r34 by targeting the PI3K/Akt pathway. These chemicals disrupt the signaling cascade crucial for receptor activation, impeding downstream events required for Vmn1r34 activation and associated cellular responses. Additionally, compounds like Rapamycin and PP242 exert their inhibitory effects indirectly by targeting the mTOR pathway, essential for Vmn1r34 activation. These inhibitors highlight the intricate interplay of signaling molecules and cellular pathways that collectively contribute to the inhibition of Vmn1r34, shedding light on the molecular basis of chemosensory signaling mediated by this receptor.
In summary, the inhibition of Vmn1r34 involves the targeted disruption of specific signaling pathways critical for its activation. The outlined chemicals act as molecular tools to interfere with these pathways, directly or indirectly inhibiting Vmn1r34 and influencing the associated cellular responses. Understanding the modulation of these pathways provides valuable insights into the intricate molecular mechanisms governing the chemosensory functions mediated by Vmn1r34. Further research in this direction could unravel additional details about the physiological implications of Vmn1r34 inhibition, contributing to a more comprehensive understanding of chemosensory signaling in diverse biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits Vmn1r34 by blocking the PI3K/Akt pathway, crucial for receptor activation. By disrupting this signaling cascade, Wortmannin impedes the downstream events required for Vmn1r34 activation and associated cellular responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 acts as a direct inhibitor of Vmn1r34 by targeting the PI3K/Akt pathway. Its interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits Vmn1r34 indirectly by targeting the mTOR pathway, essential for receptor activation. By disrupting mTOR signaling, Rapamycin interferes with the downstream events crucial for Vmn1r34 activation and associated cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 serves as a direct inhibitor of Vmn1r34 by targeting the MAPK/ERK pathway. Its interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 acts as a direct inhibitor of Vmn1r34 by targeting the MAPK/ERK pathway. Its interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits Vmn1r34 by targeting the p38 MAPK pathway. Its interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 acts as a direct inhibitor of Vmn1r34 by targeting the JNK pathway. Its interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
PD 166866 | 192705-79-6 | sc-208154 | 5 mg | $300.00 | 1 | |
PD 166866 inhibits Vmn1r34 indirectly by targeting the PI3K/Akt pathway, crucial for receptor activation. By disrupting this signaling cascade, LY303511 interferes with the downstream events required for Vmn1r34 activation and associated cellular responses. | ||||||
PI 3-Kγ Inhibitor | 648450-29-7 | sc-203191 | 5 mg | $76.00 | ||
PI 3-Kγ Inhibitor's interference with this signaling cascade disrupts the necessary events for Vmn1r34 activation and associated cellular responses. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
PP242 inhibits Vmn1r34 indirectly by targeting the mTOR pathway, essential for receptor activation. By disrupting mTOR signaling, PP242 interferes with the downstream events crucial for Vmn1r34 activation and associated cellular responses. | ||||||